Goodpasture syndrome differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
== Differential Diagnosis == | == Differential Diagnosis == | ||
Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage. ANCA associated vasculitis, are disorders that affect the renal and pulmonary system, must be differentiated from Goodpasture syndrome.<ref name=" | Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage. ANCA associated vasculitis, are disorders that affect the renal and pulmonary system, must be differentiated from Goodpasture syndrome.<ref name="pmid25462583">{{cite journal| author=Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Pagliuca G et al.| title=Goodpasture's syndrome: a clinical update. | journal=Autoimmun Rev | year= 2015 | volume= 14 | issue= 3 | pages= 246-53 | pmid=25462583 | doi=10.1016/j.autrev.2014.11.006 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25462583 }} </ref> | ||
===Differentiating Goodpasture syndrome from Other Diseases=== | ===Differentiating Goodpasture syndrome from Other Diseases=== | ||
Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage, and include:<ref name=" | Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage, and include:<ref name="pmid25462583">{{cite journal| author=Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Pagliuca G et al.| title=Goodpasture's syndrome: a clinical update. | journal=Autoimmun Rev | year= 2015 | volume= 14 | issue= 3 | pages= 246-53 | pmid=25462583 | doi=10.1016/j.autrev.2014.11.006 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25462583 }} </ref> | ||
* Granulomatosis with polyangiitis | * Granulomatosis with polyangiitis | ||
* Eosinophilic granulomatosis with polyangiitis | * Eosinophilic granulomatosis with polyangiitis |
Revision as of 19:10, 4 November 2016
Goodpasture syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Goodpasture syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Goodpasture syndrome differential diagnosis |
Risk calculators and risk factors for Goodpasture syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]
Overview
Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage. ANCA associated vasculitis, are disorders that affect the renal and pulmonary system, must be differentiated from Goodpasture syndrome.[1]
Differential Diagnosis
Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage. ANCA associated vasculitis, are disorders that affect the renal and pulmonary system, must be differentiated from Goodpasture syndrome.[1]
Differentiating Goodpasture syndrome from Other Diseases
Goodpasture syndrome must be differentiated from other diseases that cause rapid progressive glomerulonephritis and pulmonary hemorrhage, and include:[1]
- Granulomatosis with polyangiitis
- Eosinophilic granulomatosis with polyangiitis
- Microscopic polyangiitis
- Systemic lupus erythematosis
- Henoch-Schonlein purpura
- Microscopic polyarteritis
It is of extreme importance that Goodpasture syndrome be differentiated from Granulomatosis with polyangiitis as antineutrophil cytoplasmic antibodies can be seen in patients with Goodpasture syndrome.
References
- ↑ 1.0 1.1 1.2 Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Pagliuca G; et al. (2015). "Goodpasture's syndrome: a clinical update". Autoimmun Rev. 14 (3): 246–53. doi:10.1016/j.autrev.2014.11.006. PMID 25462583.